Activity – Page 6

Angela Hwang Joins Flagship Pioneering as CEO-Partner and CEO of Metaphore Biotechnologies

7 months ago talkbio0Tagged Appointments, Biotechnology, Flagship, Hwang, Leadership, Metaphore, Pfizer, Pioneering

Angela Hwang, Flagship Pioneering, Metaphore Biotechnologies, Pfizer, Biotechnology, Leadership Appointment

Vaccine Stocks Plummet Globally Following RFK Jr.’s Nomination to Head HHS

7 months ago talkbio0Tagged Appointments, CHARGE Syndrome, Impact food supplement, Market, pharmaceutical companies, RFK Jr., stocks, Vaccines

RFK Jr., HHS appointment, vaccine stocks, pharmaceutical companies, stock market impact

Empowering Undergraduates: Johns Hopkins BME Design Team Transforms Healthcare Solutions

7 months ago talkbio0Tagged biomedical engineering field, Clinical Challenges, Design, Entrepreneurship, healthcare innovation, Intellectual Property, Principles, projects, regulatory frameworks, Team, Team-Based, Undergraduate Design

Biomedical Engineering, Undergraduate Design Team, Healthcare Innovation, Clinical Challenges, Design Principles, Team-Based Projects, Entrepreneurship, Intellectual Property, Regulatory Frameworks

Gilead Withdraws US Indication for Sacituzumab Govitecan in Metastatic Urothelial Cancer

7 months ago talkbio0Tagged Accelerated, Approved, Govitecan, Malignant neoplasm of urinary bladder, sacituzumab, Trodelvy, United States Food and Drug Administration, urothelial cancer, Withdraw (activity)

Sacituzumab Govitecan, Trodelvy, Bladder Cancer, Urothelial Cancer, Gilead Sciences, FDA, Accelerated Approval Withdrawal

Jasper Therapeutics Escalates Dose in Hives Trial Following Rapid Complete Responses

8 months ago talkbio0Tagged briquilimab, chronic, Clinical Research, Clinical Trials, Dosage, Escalation, SPOTLIGHT, Urticaria

Jasper Therapeutics, briquilimab, chronic inducible urticaria, hives, dose escalation, clinical trial, SPOTLIGHT study

Teva Pharmaceuticals Agrees to $450M Settlement Over Kickback and Price-Fixing Allegations

8 months ago talkbio0Tagged Copaxone, False, Kickbacks, Medicare, Price Fixing, Settlement and Resettlement, Teva Pharmaceuticals

Teva Pharmaceuticals, False Claims Act, Anti-Kickback Statute, price-fixing, kickbacks, settlement, generic drugs, Medicare, Copaxone

Pfizer Terminates Development of Oral RSV Medication Sisunatovir Due to Ongoing Challenges

8 months ago talkbio0Tagged Acquisition (action), Clinical Development, Pfizer, Respiratory syncytial virus, ReViral, RSV, sisunatovir, Termination - Inactive Reason Code

Pfizer, ReViral, RSV, Sisunatovir, Acquisition, Clinical Development, Termination

Novo Nordisk and Viatris Settle Patent Dispute Over Ozempic and Wegovy, Keeping Generic Entry Date Undisclosed

8 months ago talkbio0Tagged Agreement, Generic Entry, Legal patent, Mylan, Nordisk, Settlement and Resettlement, Viatris, Wegovy

Novo Nordisk, Viatris, Mylan Pharmaceuticals, Ozempic, Wegovy, Patent Dispute, Generic Entry Date, Settlement Agreement

Optimizing Expression of Multi-chain and Bispecific Antibodies: Strategies and Considerations

8 months ago talkbio0Tagged Antibodies, Antibodies, Bispecific, Cells, Chinese Hamster Ovary, CHO, Cultured Cell Line, expression vector, Metabolic Engineering, Optimization, production, Recombinants, Stable status

Bispecific Antibodies (bsAbs), Recombinant Antibody Production, Chinese Hamster Ovary (CHO) Cells, Expression Vector Optimization, Metabolic Engineering, Stable Cell Line Development

J&J and Legend’s Carvykti Demonstrates Significant Survival Benefit in Earlier-Line Multiple Myeloma Treatment

8 months ago talkbio0Tagged Benefit, CAR-T, CARTITUDE-4, Carvykti, Continuance of life, Johnson & Johnson, Legend Biotech, Multiple Myeloma, second-line

Carvykti, multiple myeloma, CAR-T therapy, Johnson & Johnson, Legend Biotech, CARTITUDE-4, survival benefit, second-line treatment